Real-world pharmacovigilance study of FDA adverse event reporting system events for finerenone
Our study identified significant novel adverse events (AEs) signals for finerenone that could provide support for clinical monitoring of and risk identification for finerenone.
Authors
- Youqi Huang
- Mingyu Chen (ORCID: https://orcid.org/0000-0001-5113-754X)
- Xiaowen Chen (ORCID: https://orcid.org/0000-0002-3353-7563)
- Yuze Lin
- Min Chen (ORCID: https://orcid.org/0000-0001-8944-0691)
- Hongjin Gao
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1080/14740338.2024.2412218
- Citations
- 3
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.05